title: Association of major histocompatibility complex determinants with the development of symptomatic and asymptomatic genital herpes simplex virus type 2 infections.
abstract: The clinical spectrum of herpes simplex virus (HSV) infections, ranging from asymptomatic to frequently distressing outbreaks, suggests that there may be immunologic determinants of disease severity that are associated with human leukocyte antigen (HLA) expression. A controlled, prospective study identified several major histocompatibility complex (MHC) class I and II antigens whose frequencies are associated with HSV-2 infection or with frequent symptomatic genital recurrences. Previous studies were hampered by the inability to serologically identify patients with asymptomatic HSV-2 infection. Clinical evaluation and Western blot assay were used to identify 3 subject cohorts: 1 with no prior HSV infections, 1 with HSV-2 antibodies but no recognized symptoms, and 1 with HSV-2 antibodies and frequent genital recurrences. Statistical comparisons of HLA frequencies among these cohorts showed associations of HLA-B27 and -Cw2 with symptomatic disease. Also, HLA-Cw4 was significantly associated with HSV-2 infection. These associations indicate that immunologic factors linked to the MHC influence the risk of HSV-2 infection and disease expression.
authors: Medical Virology Section, Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. juliel@nhgri.nih.gov
authors: J A
authors: JA
authors: Lekstrom-Himes
authors: P
authors: P
authors: Hohman
authors: T
authors: T
authors: Warren
authors: A
authors: A
authors: Wald
authors: J M
authors: JM
authors: Nam
authors: T
authors: T
authors: Simonis
authors: L
authors: L
authors: Corey
authors: S E
authors: SE
authors: Straus
mesh_terms: D000328:Adult; D000483:Alleles; D000914:Antibodies, Viral / Q000097:blood; D015153:Blotting, Western; D015331:Cohort Studies; D005260:Female; D005787:Gene Frequency; D005805:Genes, MHC Class I; D005802:Genes, MHC Class II; D006680:HLA Antigens / Q000235:genetics*; D015796:HLA-B27 Antigen / Q000235:genetics; D015236:HLA-C Antigens / Q000235:genetics; D006558:Herpes Genitalis / Q000276:immunology* / Q000473:pathology / Q000821:virology; D018258:Herpesvirus 2, Human / Q000276:immunology; D006801:Humans; D008297:Male; D011446:Prospective Studies
chemical_list: D000914:Antibodies, Viral; D006680:HLA Antigens; D015796:HLA-B27 Antigen; D015236:HLA-C Antigens